A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participants
Clinical trial NCT05791318 · COMPLETED
Trial details
- NCT number
- NCT05791318
- Sponsor
- Invivyd, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2024-05-08
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.